Skip to main content
. 2011 Dec 20;6(2):191–207. doi: 10.1007/s12105-011-0320-9

Table 11.

Combined patient outcome

All patients A, NED A, D D, NED D, D
All patients with follow-up (mean years) 34 (7.6) 16 (9.6) 4 (2.5) 6 (12.4) 8 (2.3)
Follow-up range (years) 0.2–29.3 0.5–29.3 0.5–5 4.5–26.2 0.2–4.5
Gender (P = 0.162)
 Females 14 (9.9) 8 (8.9) 1 (1.6) 4 (15.9) 1 (2.0)
 Males 19 (5.9)  8 (10.4) 3 (2.8) 1 (4.5) 7 (2.3)
Age (P = 0.450)
 <60 years 17 (8.6) 11 (10.5) 2 (1.8) 2 (12.8) 2 (0.5)
 ≥60 years 18 (6.5) 5 (7.8) 2 (3.3) 4 (12.1) 6 (2.9)
Size (P = 0.034)
 <4.0 cm 19 (11.1) 11 (12.8) 2 (1.1) 4 (15.0) 2 (3.9)
 ≥4.0 cm 4 (3.1) 0 0 1 (8.3) 3 (1.4)
Anatomic site (P = 0.032)
 Nasal cavity alone 13 (11.3) 7 (14.5) 1 (0.5) 4 (10.0) 1 (4.5)
 Maxillary sinus alone 10 (7.9) 4 (8.8) 1 (3.0) 2 (17.1) 3 (2.2)
 Mixed 10 (2.6) 5 (3.5) 1 (1.6) 0 4 (1.8)
 Ethmoid sinus alone 1 (5.0) 0 1 (5.0) 0 0
Grade (P = 0.084)
 1 (L) 16 (9.9) 12 (9.9) 1 (0.5) 2 (17.2) 1 (4.5)
 2 (I)a 6 (9.3) 1 (29.3) 1 (1.6) 1 (21.1) 3 (1.2)
 3 (H)a 12 (3.5) 3 (1.9) 2 (4.0) 3 (6.2) 4 (2.5)
Stage (P = 0.027)
 I 13 (11.0) 8 (10.5) 2 (4.0) 3 (17.3) 0
 II 10 (9.3) 5 (13.1) 0 3 (7.5) 2 (2.9)
 III 7 (1.8) 2 (1.7) 1 (1.6) 0 4 (1.8)
 IV 4 (1.9) 1 (2.0) 1 (0.5) 0 2 (2.5)
Patients with recurrence (P = 0.041) 14 (4.5) 4 (9.9) 3 (3.2) 0 7 (2.0)
Patients without recurrence 19 (10.2) 12 (9.5) 0 6 (12.4) 1 (4.5)

Current study with literature [1631]

A, NED alive, no evidence of disease; A, D alive, with disease; D, NED dead, no evidence of disease; D, D dead, with disease; L low; I intermediate; H high

aFollow-up was not available for a number of patients